CureSearch combats the loss of promising scientists from the field by providing significant financial support to investigators early in their research career. Early-career investigators are the most vulnerable to federal funding shortages, and they rely more than ever on the support of private foundations like CureSearch in order to continue their research.
These grants are limited to truly transformational science designed to deliver the next generation of cancer treatment. Starting in 2012, CureSearch initially supported 12 Young Investigators in research areas with high risk and low outcomes for children with cancer: relapsed ALL, AML, brain tumors, Ewing sarcoma, hepatoblastoma, Hodgkin disease, neuroblastoma, non-Hodgkin lymphoma, rhabdomyosarcoma, survivorship/late effects, adolescent and young adult cancer, and Wilms tumor.
Encouraged by the promise and success of our first 12 Young Investigators, CureSearch recently awarded 6 new grants. The new grant term is 3 years and the award has more than doubled, allowing for even more young researchers to establish a sustainable model from the outset of their research.
Young Investigator-2 (2015-2017)
CureSearch recently announced $1.3 million in new grant funding for Young Investigators pursuing innovative projects in childhood cancer research. The Young Investigator-2 awards provide $75,000 in funding per year over 3 years, an increase in the award amount and timeframe from Young Investigator-1.
Young Investigator-1 (2012-2014)
In 2012, CureSearch began funding 12 Young Investigators, each for 2 years, in areas of study that represent the highest risk with the poorest outcomes for children with cancer.